NCT06250335View on ClinicalTrials.gov

Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

January 23, 2027

Study Completion Date

January 23, 2029

Conditions
ICB-refractory Melanoma
Interventions
OTHER

Prebiotic Food-Enriched Diet

Given by PO

DRUG

Ipilimumab

Given by IV

DRUG

Nivolumab

Given by IV

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT06250335 - Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients | Biotech Hunter | Biotech Hunter